Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 4
1982 4
1983 2
1984 1
1985 1
1986 1
1987 4
1988 1
1989 2
1990 3
1994 2
1995 4
1996 2
1997 2
1998 2
1999 1
2000 2
2003 2
2004 2
2006 3
2007 4
2008 4
2009 4
2010 3
2011 5
2012 4
2013 3
2014 4
2015 9
2016 12
2017 15
2018 25
2019 21
2020 27
2021 12
Text availability
Article attribute
Article type
Publication date

Search Results

175 results
Results by year
Filters applied: . Clear all
Page 1
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Kasner SE, Swaminathan B, Lavados P, Sharma M, Muir K, Veltkamp R, Ameriso SF, Endres M, Lutsep H, Messé SR, Spence JD, Nedeltechev K, Perera K, Santo G, Olavarria V, Lindgren A, Bangdiwala S, Shoamanesh A, Berkowitz SD, Mundl H, Connolly SJ, Hart RG; NAVIGATE ESUS Investigators. Kasner SE, et al. Among authors: perera k. Lancet Neurol. 2018 Dec;17(12):1053-1060. doi: 10.1016/S1474-4422(18)30319-3. Epub 2018 Sep 28. Lancet Neurol. 2018. PMID: 30274772 Free PMC article. Clinical Trial.
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE, Haeusler KG, Mikulik R, Kasner SE, Toni D, Arauz A, Ntaios G, Hankey GJ, Perera K, Pagola J, Shuaib A, Lutsep H, Yang X, Uchiyama S, Endres M, Coutts SB, Karlinski M, Czlonkowska A, Molina CA, Santo G, Berkowitz SD, Hart RG, Connolly SJ. Healey JS, et al. Among authors: perera k. JAMA Neurol. 2019 Jul 1;76(7):764-773. doi: 10.1001/jamaneurol.2019.0617. JAMA Neurol. 2019. PMID: 30958508 Free PMC article. Clinical Trial.
Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
Ameriso SF, Amarenco P, Pearce LA, Perera KS, Ntaios G, Lang W, Bereczki D, Uchiyama S, Kasner SE, Yoon BW, Lavados P, Firstenfeld A, Mikulik R, Povedano GP, Ferrari J, Mundl H, Berkowitz SD, Connolly SJ, Hart RG. Ameriso SF, et al. Among authors: perera ks. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104936. doi: 10.1016/j.jstrokecerebrovasdis.2020.104936. Epub 2020 Jun 8. J Stroke Cerebrovasc Dis. 2020. PMID: 32689594 Clinical Trial.
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
Veltkamp R, Pearce LA, Korompoki E, Sharma M, Kasner SE, Toni D, Ameriso SF, Mundl H, Tatlisumak T, Hankey GJ, Lindgren A, Berkowitz SD, Arauz A, Ozturk S, Muir KW, Chamorro Á, Perera K, Shuaib A, Rudilosso S, Shoamanesh A, Connolly SJ, Hart RG. Veltkamp R, et al. Among authors: perera k. JAMA Neurol. 2020 Oct 1;77(10):1233-1240. doi: 10.1001/jamaneurol.2020.1995. JAMA Neurol. 2020. PMID: 32628266 Free PMC article. Clinical Trial.
Interactions of viruses and the humoral innate immune response.
Maloney BE, Perera KD, Saunders DRD, Shadipeni N, Fleming SD. Maloney BE, et al. Among authors: perera kd. Clin Immunol. 2020 Mar;212:108351. doi: 10.1016/j.clim.2020.108351. Epub 2020 Feb 4. Clin Immunol. 2020. PMID: 32028020 Free PMC article. Review.
Statin treatment and cerebral microbleeds: A systematic review and meta-analysis.
Katsanos AH, Lioutas VA, Charidimou A, Catanese L, Ng KKH, Perera K, de Sa Boasquevisque D, Falcone GJ, Sheth KN, Romero JR, Tsivgoulis G, Smith EE, Sharma M, Selim MH, Shoamanesh A; International META-MICROBLEEDS Initiative. Katsanos AH, et al. Among authors: perera k. J Neurol Sci. 2021 Jan 15;420:117224. doi: 10.1016/j.jns.2020.117224. Epub 2020 Nov 8. J Neurol Sci. 2021. PMID: 33183779
175 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page